Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators - Wikidata - awgldk - TriplyDB

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

http://www.wikidata.org/entity/Q36879456

about

The role of lipoxin A4 in endometrial biology and endometriosis Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction Fast food fever: reviewing the impacts of the Western diet on immunity Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques Roles of resolvins in the resolution of acute inflammation Mammalian lipoxygenases and their biological relevance The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions Resolvin D1 binds human phagocytes with evidence for proresolving receptors Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32 Functional and pathological roles of the 12- and 15-lipoxygenases Fish oil metabolites: translating promising findings from bench to bedside to reduce cardiovascular disease Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome Relationships among stress measures, risk factors, and inflammatory biomarkers in law enforcement officers Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1 D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.Phenotypic polarization of macrophages in atherosclerosis Phenotypic modulation of macrophages in response to plaque lipids.Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.Improved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions.Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach Pro-resolving lipid mediators are leads for resolution physiology.The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats.Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.Specialized pro-resolving lipid mediators in the inflammatory response: An update Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Vagus nerve controls resolution and pro-resolving mediators of inflammation Macrophage death and defective inflammation resolution in atherosclerosis.Inflammation and its resolution as determinants of acute coronary syndromes.Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis.Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.12/15-lipoxygenase is an interleukin-13 and interferon-γ counterregulated-mediator of allergic airway inflammation.

P2860

Q24564121-1072E128-06FD-49D6-A935-D576A540EAE1 Q24648717-8100DA5F-FAC2-4E0B-8EFE-697BE4919A60 Q26738772-FCA3D38E-B704-456C-9BA2-BC0A34DF585D Q26746944-96B2EBEC-D7D6-4012-8388-989F1BF51B53 Q26852026-FEE35C40-FEBC-445F-BB90-4370326A06A8 Q27028109-100BD571-660C-4AB7-BDD9-63A702D5FC4A Q27333694-B58287D5-DFAE-4692-A56B-ECFD711D9469 Q28244502-4ADA71B2-618F-42DC-9395-EFBD43177BAE Q28249730-EDD477CC-DCE6-41B6-90A4-E8406A7F1285 Q28260186-2262604C-4E7C-4A41-9AD3-91B3CBCB74EC Q28264433-D5349D42-38E7-403C-9423-B8E2BCB88DAF Q28270638-C3AC7CE7-8EB9-42AA-817F-F9FA67F748DA Q28274076-E8985C30-B6ED-4191-95C7-D26E379C1107 Q28296453-51954B78-2660-43C8-BC57-6960C9755EB6 Q28385429-1A5EAFCE-6CC8-4928-8CFE-9358B982D707 Q28387661-E5571454-891E-4364-BCF5-D06073051257 Q28392174-0BA993C4-505E-4382-9055-3A84C63629C7 Q28740401-A44BE524-8E79-405A-9B07-095232EDFB0E Q30275955-B879403D-162F-4AA1-8131-B5814189C621 Q30412717-14A716BF-F948-400E-ABAC-F25414A3DCDF Q30413906-099D0E1D-8E69-4294-BA83-DD128202EEDC Q30418648-7EA59207-D8FB-43F1-BC6A-F6F1AAF4246B Q30434202-6F4C14DA-5328-492E-B14B-0D616B27D8BA Q30434669-DB23918A-66C0-4D63-9AAA-E74AF2BCB46B Q30530417-AFDDBF4E-A6D3-4045-86E0-B5674E47BFE6 Q30576012-24DA34CB-B661-42F1-86BA-9F85B5132BBA Q30829097-DDF899E3-A5F9-452F-B20E-5033D63C08B1 Q33458930-AE437EA5-7685-45C7-9A38-B68C7C33F726 Q33578073-B70FF760-A26C-4E3F-AED1-C67430B16AC8 Q33644481-B6F8555D-045A-4A7D-B7E9-E264422C1254 Q33657562-A5676CE2-E7E6-49C0-83BC-D9AB685F780C Q33683210-BEF7F153-4786-426A-B498-45274EFAB010 Q33703024-2970D055-2AF3-4C58-A898-7AE98FC146A2 Q33789327-3EF0F3B6-6491-41CE-B961-E75E651B83B8 Q33834800-A38051B4-9A10-4A63-857F-363D2F1DFE65 Q34065741-CEBFA019-9276-4CDC-8E44-E11FF91A4CF6 Q34113615-6CB2B342-80D6-4333-BBD2-DEDAE2015F1A Q34127214-CF2E7BD5-9AA5-4A67-825E-58A8139B8C4C Q34162546-799421AF-0A92-4C7A-B579-65E89BC1A116 Q34189821-9A9F68E1-F378-4DFD-B32E-C7F22F9A5FAC

P2860

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

http://www.wikidata.org/entity/Q36879456

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Atherosclerosis: evidence for ...... ed by specific lipid mediators

@en

type

label

Atherosclerosis: evidence for ...... ed by specific lipid mediators

@en

prefLabel

Atherosclerosis: evidence for ...... ed by specific lipid mediators

@en

P1433

Q36879456-698C3E72-5735-4F9F-B23C-1B91D4981CE9

P1476

Q36879456-637DDE7E-72B6-4862-BBDC-C042E03ABC2A

P2093

Q36879456-147AB225-1A2C-4CCF-A198-34D132DE00E5

Q36879456-184F93B7-93FD-4A60-A450-83F0ABE16723

Q36879456-5BDD378D-B20D-4C76-8E2F-4F784713E46E

Q36879456-B5006593-FB5F-424C-8A4B-457F79B72164

Q36879456-FFA928B9-8AAB-4814-8F52-E5ECC3A8B350

P2860

Q36879456-0075ED38-3E48-43C8-8D82-BC87CE873503

Q36879456-0AD6F780-205A-4121-AEB6-3259502C108D

Q36879456-0CE9F2A9-9430-4ED6-9086-377DD94133F4

Q36879456-17577980-102E-4E8D-A48D-1C76990E021A

Q36879456-19C2DCC4-EBA7-420B-8149-65E536C2FECB

Q36879456-19EAA99A-1132-4EC9-9D10-BDF43D403029

Q36879456-2119A5A0-D0CD-4C98-A04E-462C7E45AA8C

Q36879456-2714389D-F669-4E37-A6F3-F4AE1B5E07E4

Q36879456-2A7707D0-1A31-4E2D-A589-BBF571FCD896

Q36879456-3C890772-3EA6-4BA1-B09C-077A79B25968

P304

Q36879456-C11C2AC2-36CE-432F-ACD6-0C470720F3E8

P31

Q36879456-CDF7EF21-EC3E-4CB5-A0EC-6174DAAACD74

P356

Q36879456-7EB98D78-D64D-440E-919F-B579A502942F

P407

Q36879456-1E59B1BD-5987-485C-BAC4-E2CD40AB2E67

P433

Q36879456-AFBCA76C-1559-41A8-A6FD-CAFB4C65AFA4

P478

Q36879456-F4B08516-69F2-46AD-9311-3501AC7DFD30

P577

Q36879456-1FB279B0-88D5-4FAF-8C7C-B7C4DE2135AD

P5875

Q36879456-22B363A0-8E52-4D8A-9125-39FC60FB3BF4

P698

Q36879456-F4E771E3-9C3D-4C5F-A119-C762A75E455A

P921

Q36879456-04B68A21-70F2-4F51-A35B-2BF3D36E0CC4

P932

Q36879456-C86F3106-5AAC-444D-B0EE-8697D59D6EC8

P356

P1433

P1476

Atherosclerosis: evidence for ...... ed by specific lipid mediators

@en

P2093

Aksam J Merched

http://www.w3.org/2001/XMLSchema#string

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Katherine H Gotlinger

http://www.w3.org/2001/XMLSchema#string

Kerry Ko

http://www.w3.org/2001/XMLSchema#string

Lawrence Chan

http://www.w3.org/2001/XMLSchema#string

P2860

12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Lipoxins: pro-resolution lipid mediators in intestinal inflammation

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

Inflammation, atherosclerosis, and coronary artery disease

P304

3595-3606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.08-112201

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5296710

http://www.w3.org/2001/XMLSchema#string

P698

18559988

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2537438

http://www.w3.org/2001/XMLSchema#string